HOME >> BIOLOGY >> NEWS
Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24

The 24th Annual Meeting and Scientific Session of the International Society for Heart and Lung Transplantation (ISHLT) will feature presentations and debate on advances and emerging technologies in the fields of late stage heart and lung failure, thoracic transplantation, cell transplantation, and tissue engineering and related infectious disease. Held April 21-24 at the Hilton San Francisco, the meeting will feature original research, plenary sessions and lectures for more than 2,000 attendees from around the globe.

LATE-BREAKING RESULTS FROM CLINICAL TRIALS

Attending media will be the first to learn the results of high-impact transplantation clinical trials presented during special plenary sessions. These include:

  • The use of genomic medicine to enhance outcomes in heart transplant recipients
  • Definitive studies of newer distinctive strategies of immunosuppression to decrease rejection rates. Immunosuppression involves the medical suppression of the immune system to prevent organ transplant rejection.
  • The latest information on the impact of novel immunosuppression in tackling coronary artery disease after transplantation using intravascular ultrasound
  • Use of novel drug delivery systems such as inhaled cyclosporine after lung transplantation The final scientific program and hotel information are available at www.ishlt.org/meetings.

    MEDIA ASSISTANCE

    Media with press credentials are welcome for no charge at all scientific sessions and symposia. A fully equipped and staffed press room with supplemental materials and opportunities for press briefings will be available on site from April 21-24. Every accommodation will be made to fulfill individual requests for interviews and information. Please contact Kelly Goff to register.

    Additional information about the meeting will be provided as it becomes available. If you would like to receive updates and news releas
    '"/>



  • Contact: Kelly Goff
    kellygoff@server63.com
    210-378-1980
    International Society for Heart and Lung Transplantation
    18-Mar-2004


    Page: 1 2

    Related biology news :

    1. Media advisory: Sea of Cortez expedition to launch March 26
    2. AMA Alzheimers Media Briefing
    3. Media alert: Mideast briefing
    4. Media Advisory-GSA 2003 Annual Meeting
    5. Media advisory - wildland fire impacts on watersheds
    6. Media seminar on cardiovascular medicine
    7. Media Advisory
    8. UCLA offers CASE Media fellowships on genetics, society and the individual
    9. Media alert: press briefings and special sessions at the GSAs Annual Meeting
    10. When Media, Science and Public Policy Collide: The Case of Food and Biotechnology
    11. Media invited to watch NASA Materials Science Conference on national webcast next week

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:8/14/2019)... TORONTO (PRWEB) , ... August 14, 2019 , ... Join ... live session on Tuesday, September 10, 2019 at 1pm EDT to learn ... stratification and effective management. , NAFLD is the most common diffuse liver disease, ...
    (Date:8/14/2019)... Calif. (PRWEB) , ... August 13, 2019 , ... Dr. Julie Reck of Veterinary ... to her patients. Her first stem cell patient, her own geriatric Australian Shepherd, ... According to Dr. Reck, Simon wanted to play but his body was weak, and he ...
    (Date:8/6/2019)... (PRWEB) , ... August 05, 2019 , ... Keck Graduate ... KGI School of Pharmacy and Health Sciences (SPHS). , “Dean Zdanowicz is highly regarded ... of Trustees Chairman Jim Widergren. “He is a great choice to build on the ...
    Breaking Biology News(10 mins):
    (Date:7/9/2019)... ... July 08, 2019 , ... Today, at the BIO World ... Corn Growers Association (NCGA) announced the winners of the Consider Corn Challenge II. ... process using field corn to produce biobased materials. , “Corn is a sustainable, ...
    (Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... application to the FDA for use of a person’s own adipose-derived stem cells to ... osteoarthritis in the knee. This IND is the first of several planned clinical ...
    (Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
    (Date:5/31/2019)... ... May 29, 2019 , ... ... applications from the USPTO providing proprietary interest to our methodology, processes, and ... DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep ...
    Breaking Biology Technology:
    Cached News: